Sean Bailey, MD
Otolaryngology · Kirkwood, MONPI 1013908714
Payments from drug & device makers
What this record shows
Intersect ENT, Inc. accounts for 65.2% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $3,254 and has fallen 80.7% since, to $629 in 2025.
Across 70 payments — averaging $64.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- Stryker$561
- GSK$285
- Optinose US, Inc.$254
- Acclarent, Inc$88
- Aerin Medical Inc.$71
- plus $312 from 11 others
What the payments were for
- Travel & lodging$2,31851%
- Food & beverage$2,19349%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 11 | $2,942 |
| Stryker | 17 | $561 |
| GSK | 7 | $285 |
| Optinose US, Inc. | 12 | $254 |
| Acclarent, Inc | 3 | $88 |
| Aerin Medical Inc. | 3 | $71 |
| Integra Lifesciences Corporation | 1 | $46 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $46 |
| Sanofi | 3 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Medtronic(2 entities) | 2 | $31 |
| Kaleo, Inc. | 2 | $29 |
| Alk-abello, Inc | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$2,844
- SINUVA$2,648
- NUCALA$231
- XPRESS ENT DILATION SYSTEM$128
- SCOPIS ENT$107
How this compares
$4,511 in reported general payments places this provider in the 85th percentile of 210 otolaryngology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 574 | $14,875 |
| Fluocinolone Acetonide Oil | 139 | $7,030 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 120 | $5,759 |
| Epinephrine | 28 | $4,562 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 34 | $3,376 |
| Ipratropium Bromide | 61 | $1,881 |
| Methylprednisolone | 265 | $1,637 |
| Famotidine | 81 | $1,314 |
| Pantoprazole Sodium | 66 | $1,119 |
| Doxycycline Hyclate | 100 | $879 |
| Mometasone Furoate | 63 | $858 |
| Mupirocin | 127 | $795 |
| Rabeprazole Sodium | 16 | $563 |
| Ciprofloxacin Hcl | 64 | $463 |
| Cephalexin | 29 | $441 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Kirkwood
- Frederic PuglianoKirkwood$6K
- Joseph BradleyKirkwood$3K
- Talon ManingasJoplin$314K
- Ryan JacksonSaint Louis$284K
- Ravindra UppaluriSaint Louis$168K
- James GouldFestus$143K
- John SchneiderSaint Louis$74K
- Amit WaliaSaint Louis$21K
- Bharat PanugantiSaint Louis$19K
- Jeffrey SharonSt. Louis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.